REG - CML Microsystems PLC - Block listing Interim Return

CML MicrosystemsAnnouncement

26/03/2020 17:10

RNS Number : 7800H
  
CML Microsystems PLC
  
26 March 2020
  
 

BLOCK LISTING INTERIM RETURN
 
Date: 26 March 2020
 




Name of applicant:


CML Microsystems Plc




Name of scheme:


CML Share Option Scheme




Period of return:


From:


25 September 2019


To:


24 March 2020




Balance of unallotted securities under scheme(s) from previous return:


599,587 ordinary shares of 5p each




Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):


-




Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):


(33,128) ordinary shares of 5p each




Equals:  Balance under scheme(s) not yet issued/allotted at end of period:


566,459 ordinary shares of 5p each



 
 
 
 
 



 




Name of contact:


Nigel Clark, Group Financial Director




Telephone number of contact:


01621 875500




 
 
Total Voting Rights
 
In conformity with the Financial Conduct Authority's Disclosure and Transparency rules, CML Microsystems Plc hereby notifies the market that the Company's issued share capital comprises 17,177,652 ordinary shares of 5p each. All of these shares carry voting rights. In addition to these 17,177,652 ordinary shares, the total number of treasury shares held is 23,467 which do not carry voting rights.  
 
The above figure of 17,177,652 ordinary shares in the Company carrying voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
BLRPPUCAWUPUGQQ